PerkinElmer acquires German diagnostics company
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
PerkinElmer Inc. completed its previously announced acquisition of EUROIMMUN Medical Laboratory Diagnostics AG for $1.3 billion in cash.
EUROIMMUN develops laboratory reagents to be used for the diagnosis of autoimmune and infectious diseases and allergies.
